Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal Dosage of Sildenafil for Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia
KCT0001722Phase 2Completed
- Sponsor
- Hanmi Pharmaceutical
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sildenafil in benign prostatic hyperplasia (BPH), Micturition disorder, sponsored by Hanmi Pharmaceutical. Started Jul 2013; status: completed.
02
Drugs
sildenafil
03
Conditions
benign prostatic hyperplasia (BPH)Micturition disorder
Beyond the preview
Go deeper on KCT0001722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001722.